The market is projected to grow at a CAGR of 21.39% from 2026 to 2034
Both the classes share number of conserved residues in the N-terminal GSH binding domain and possess a distinct structural feature of N-terminal extension (Theodoulou et al., 2003)
The dose-escalation structure is built into the FDA labeling because nausea, vomiting, diarrhea, constipation, dyspepsia, and abdominal pain are among the most common adverse reactions
Alcohol uses many of the same metabolic pathways as acetaminophen
Clinicians should monitor thyroid function tests (TSH, free T4) at: Baseline before starting weight loss injections 6-8 weeks after achieving maintenance dose Every 3-6 months during active weight loss After significant weight stabilization Symptoms of overreplacement (palpitations, anxiety, tremor, heat intolerance) should prompt earlier testing